Guardium’s products are currently deployed in 350 data centers worldwide, including more than 60 Global 500 and Fortune 1000 companies in government, financial services, energy, manufacturing, telecommunications, pharmaceuticals, transportation, biotech, and media and entertainment sectors.
The company’s flagship products include:
- HealthGuard, which creates vulnerability assessment based on real-time analysis of security metrics, auto-discovers entire database environment, and produces an interactive visual access map with drill-down details about various database access activities
- AuditGuard, which generates audit and compliance reports on a scheduled basis, and distributes reports to stakeholders
- PolicyGuard, which provides real-time enforcement and peremptory blocking of transactions that violate security policies, as well as creates policy-based alerts based on real-time events and statistical thresholds, and prevents suspicious and unauthorized access.
Guardium is privately held and headquartered in Waltham, Massachusetts. It also holds R&D centers in Ramat-Gan. The company is currently led by CEO Ram Metser. Guardium’s software suite competes with Israel’s Imperva (founded by Shlomo Kramer of Checkpoint’s fame) and Sentrigo, a database security start up backed by Benchmark Israel. Both companies could by potential targets for acquisition in the near term.
This is IBM’s ninth Israeli M&A deal. It also comes in good timing for the Israeli venture capital industry, which has struggled with exits.
- Israeli Tech Scene Shows Glimmers of Recovery in Q1 2024 - April 30, 2024
- Gaming Investments Level Up: Early Signs of a Resurgence - April 24, 2024
- What could go wrong with Vinod Khosla’s techno-optimistic vision of the future - April 22, 2024